These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3512902)

  • 1. Natural killer cell activity against a thymoma cell line Thy 121 in bone marrow transplant recipients.
    Heidemann E; Schmidt H; Schüch K; Ostendorf P; Waller HD
    Klin Wochenschr; 1986 Feb; 64(3):125-30. PubMed ID: 3512902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NK and K cell activity in children with leukemias and aplastic anemias before and after allogeneic bone marrow transplantation].
    Thränhardt H; Prager J; Fuchs D; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):285-92. PubMed ID: 2410337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT.
    Keever CA; Klein J; Leong N; Copelan EA; Avalos BR; Kapoor N; Cunningham I; Tutschka PJ
    Bone Marrow Transplant; 1993 Sep; 12(3):289-95. PubMed ID: 8241989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.
    Storb R; Deeg HJ; Whitehead J; Farewell V; Appelbaum FR; Beatty P; Bensinger W; Buckner CD; Clift RA; Doney K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2608-13. PubMed ID: 3547942
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural killer cell activity in human bone marrow recipients: early reappearance of peripheral natural killer activity in graft-versus-host disease.
    Dokhelar MC; Wiels J; Lipinski M; Tetaud C; Devergie A; Gluckman E; Tursz T
    Transplantation; 1981 Jan; 31(1):61-5. PubMed ID: 7015602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
    Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation.
    Hercend T; Takvorian T; Nowill A; Tantravahi R; Moingeon P; Anderson KC; Murray C; Bohuon C; Ythier A; Ritz J
    Blood; 1986 Mar; 67(3):722-8. PubMed ID: 3081066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunogenetics of chronic graft versus host disease and its relevance for the graft versus leukemia effect.
    van Rood JJ; Goulmy E; van Leeuwen A
    Prog Clin Biol Res; 1987; 244():433-8. PubMed ID: 3310005
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell activity following T-cell depleted allogeneic bone marrow transplantation.
    Rooney CM; Wimperis JZ; Brenner MK; Patterson J; Hoffbrand AV; Prentice HG
    Br J Haematol; 1986 Mar; 62(3):413-20. PubMed ID: 3513817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemia.
    Castro-Malaspina H; Childs B; Laver J; Shank B; Brochstein J; Gillio A; Flomenberg N; Young J; Boulad F; Black P
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):847-54. PubMed ID: 8040033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
    Atkinson K; Downs K; Ashby M; Dodds A; Concannon A; Biggs J
    Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow transplantation in humans. IV. The graft versus host disease].
    Izzi T; Lucarelli G
    Recenti Prog Med; 1983 Jun; 74(6):720-32. PubMed ID: 6351202
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction.
    Atkinson K; Biggs JC; Britton K; Short R; Mrongovius R; Concannon A; Dodds A
    Br J Haematol; 1984 Feb; 56(2):223-31. PubMed ID: 6362711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological recovery after bone marrow transplantation for severe aplastic anaemia: a Brazilian experience.
    de Souza MH; Diamond HR; Silva ML; Campos MM; Bouzas LF; Tabak D; Flowers ME; Rumjanek VM
    Eur J Haematol; 1994 Sep; 53(3):150-5. PubMed ID: 7925858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation.
    Livnat S; Seigneuret M; Storb R; Prentice RL
    J Immunol; 1980 Jan; 124(1):481-90. PubMed ID: 6765970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone marrow transplantation in severe aplastic anemia and acute leukemia].
    Speck B; Sartorius J; Cornu P; Nissen C; Weber W; Gratwohl A
    Onkologie; 1979 Apr; 2(2):79-82. PubMed ID: 42865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer function following allogeneic bone marrow transplantation. Very early reemergence but strong dependence of cytomegalovirus infection.
    Hokland M; Jacobsen N; Ellegaard J; Hokland P
    Transplantation; 1988 Jun; 45(6):1080-4. PubMed ID: 2837847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.